Delivery Order SPE2DB22D2007-SPE2DB25FH8SV
Award Date
2/3/25
Potential Completion Date
2/4/25
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,824.15 delivery order contract is for the provision of Candesartan Cilexetil 32 mg tablets. The contract has a firm fixed price pricing type and runs through November 13, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,542.63 Firm Fixed Price Delivery Order covers the supply of Candesartan Cilexetil 32 mg tablets in 90-count packages. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,481.49, is a firm fixed-price delivery order for the supply of 4,567,109,988 units of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $7,570.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 16 mg tablets in 90 count packages. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with a completion date of January 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,243.97 firm-fixed-price delivery order is for the supply of 4,567,058,750 units of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of January 28, 2025 and was awarded on January 27, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,589.45 firm fixed-price delivery order is for the supply of 4,566,263,607 tablets of the generic drug Candesartan Cilexetil 32 mg. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,959.49, is for the delivery of candesartan cilexetil 32 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of October 31, 2024. The contract was awarded on October 30, 2024 and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $8,333.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, a cardiovascular medication, with a completion date of December 17, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 4 mg tablets, a cardiovascular medication, with a ceiling value of $1,216.52 and a completion date of February 3, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,235.63 firm fixed-price delivery order is for the supply of 4,566,770,606 units of Candesartan Cilexetil 8 mg tablets. The contract has a period of performance through December 20, 2024 and was awarded on December 19, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...